2022 (v1)
Publication
Background: Adalimumab is used to treat ulcerative colitis, but additional effectiveness and safety data are needed.Patients and methods: This retrospective study considered adults with ulcerative colitis treated with adalimumab at 19 hospitals. Clinical data were collected from the start of treatment, after 2, 6 and 12 months, and at the last...
Uploaded on: February 14, 2024